BioApp
Pohang
About BioApp
BioApp is a biotechnology company that aims to provide a plant-derived genetically modified subunit vaccine for swine fever prevention. The company conducts research and development of plant-based green vaccine products for swine fever and African swine fever, as well as human medicines like Corona 19.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $3.8M
- Last round: Series Unknown (Jul 2022)
- Website: bioapp.co.kr
- Phone: +82-54-279-6534
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/bioapp-142775 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.